Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and prognosis.
Wei BM, Fox LP, Kaffenberger BH, Korman AM, Micheletti RG, Mostaghimi A, Noe MH, Rosenbach M, Shinkai K, Kwah JH, Phillips EJ, Bolognia JL, Damsky W, Nelson CA.
J Am Acad Dermatol. 2024 May;90(5):885-908. doi: 10.1016/j.jaad.2023.02.072. Epub 2023 Jul 27.
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part II diagnosis and management.
Wei BM, Fox LP, Kaffenberger BH, Korman AM, Micheletti RG, Mostaghimi A, Noe MH, Rosenbach M, Shinkai K, Kwah JH, Phillips EJ, Bolognia JL, Damsky W, Nelson CA.
J Am Acad Dermatol. 2024 May;90(5):911-926. doi: 10.1016/j.jaad.2023.02.073. Epub 2023 Jul 28.
Vancomycin-associated drug-induced hypersensitivity syndrome.
Madigan LM, Fox LP.
J Am Acad Dermatol. 2019 Jul;81(1):123-128. doi: 10.1016/j.jaad.2019.02.002. Epub 2019 Feb 6.
Multiple drug hypersensitivity syndrome.
Chiriac AM, Demoly P.
Curr Opin Allergy Clin Immunol. 2013 Aug;13(4):323-9. doi: 10.1097/ACI.0b013e3283630c36.
Guidelines for the management of drug-induced hypersensitivity syndrome 2023.
Mizukawa Y, Hama N, Niihara H, Miyagawa F, Hashizume H, Tohyama M, Takahashi H, Watanabe H, Ohyama M, Yamaguchi Y, Kawamura T, Nomura T, Kabashima K, Sueki H, Morita E, Abe R, Asada H.
J Dermatol. 2025 Mar;52(3):e189-e209. doi: 10.1111/1346-8138.17609. Epub 2025 Feb 3.
Drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS): An update in 2019.
Shiohara T, Mizukawa Y.
Allergol Int. 2019 Jul;68(3):301-308. doi: 10.1016/j.alit.2019.03.006. Epub 2019 Apr 16.
Multiple Drug Hypersensitivity Syndrome in a Large Database.
Landry Q, Zhang S, Ferrando L, Bourrain JL, Demoly P, Chiriac AM.
J Allergy Clin Immunol Pract. 2020 Jan;8(1):258-266.e1. doi: 10.1016/j.jaip.2019.06.009. Epub 2019 Jun 22.
Antibacterial antibiotic-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a literature review.
Sharifzadeh S, Mohammadpour AH, Tavanaee A, Elyasi S.
Eur J Clin Pharmacol. 2021 Mar;77(3):275-289. doi: 10.1007/s00228-020-03005-9. Epub 2020 Oct 6.
Sulfonamide Hypersensitivity: Fact and Fiction.
Khan DA, Knowles SR, Shear NH.
J Allergy Clin Immunol Pract. 2019 Sep-Oct;7(7):2116-2123. doi: 10.1016/j.jaip.2019.05.034.
Clinical features of drug-induced hypersensitivity syndrome to BRAF inhibitors with and without previous immune checkpoint inhibition: a review.
Maloney NJ, Rana J, Yang JJ, Zaba LC, Kwong BY.
Support Care Cancer. 2022 Mar;30(3):2839-2851. doi: 10.1007/s00520-021-06543-9. Epub 2021 Sep 21.
